Business Insider10d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
RICHMOND, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...
Yahoo Finance22d
BioAge Labs to Present at Jefferies London Healthcare Conference
RICHMOND, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic ...
Mena FN7d
Bioage Labs Reports Third Quarter 2024 Financial Results And Provides Business Updates
Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge",“the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...
Stockhouse7d
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates ...
Stockhouse10d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting ...